North America is Dominating the Global Nucleic Acid Isolation and Purification Market with Maximum Revenue
Nucleic
acid isolation and purification is the preliminary step in the field of
molecular biology research accompanied by recombinant techniques. The nucleic
acid isolation process majorly includes enzymatic digestion and mechanical and
chemical disruption. On the other hand, purification consists of a combination
of precipitation, chromatography, centrifugation, electrophoresis, and
separation.
The
process of nucleic acid isolation aids sample processing by reducing the time,
significantly minimizes nucleic acid loss, and enhances experimental process
efficiency and effectiveness. The obtained purified product is further used in
recombinant technology methods, thereby making it suitable for targeted
purposes in the field of omics research. The advantages offered by nucleic acid
isolation and purification significantly aid scientists and researchers to
obtain high-quality starting material for conducting downstream applications,
thereby generating accurate results.
According
to the market intelligence published by BIS Research, the nucleic
acid isolation and purification market is projected to grow at a
significant CAGR of 5.98% during the forecast period, 2020-2029. The market was
estimated at $2273.9 million in 2018.
The
end users in Nucleic acid isolation and purification market are expected to witness
a wide variety of applications, and automation has further facilitated applications,
such as genomic/plasmid DNA, cell-free DNA (cfDNA), viral RNA, and cell-free
RNA (cfRNA). Automation in nucleic acid isolation and purification offers high
throughput, further reducing sample processing time.
Factors
such as the increasing prevalence of genetic diseases, rising research in the
field of molecular biology, growing awareness and acceptance of precision
medicine worldwide, and rising research funding from government and private
institutions, are further supporting the adoption of automated nucleic acid
isolation and purification products.
As
of 2019, North America was the dominating region in terms of revenue generated
in the global market. The presence of full-fledged operational units of
conglomerate companies contributing to this market significantly provided help
in the establishment of several emerging players, further contributing
significantly to the technological innovations in the nucleic acid isolation
and purification market.
Presently,
in the Europe region, Germany, the U.K., and France are the dominating
countries in the Europe nucleic acid isolation and purification market. Factors
such as growing demand for pharmaceuticals, increasing genomic research by
government and private institutions, and significant adoption of technologically
advanced nucleic acid isolation products, are expected to support the market
growth in the forthcoming years.
The
global nucleic acid isolation and purification market have a long way to go
with large, as well as small players, operating at the global and regional
levels. Some of the prominent players in this market are Promega Corporation,
F. Hoffmann-La Roche AG, Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific
Inc., and Merck KGaA.
Comments
Post a Comment